Medical Equipment

Ventricular Fibrillation Market Revenue Expected to Reach $8.56 Billion by 2030 with 5.5% CAGR

March 17, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Ventricular Fibrillation Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The market size for ventricular fibrillation has demonstrated significant expansion in recent years. This market is anticipated to expand from $6.51 billion in 2025 to $6.92 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The historical growth of this market segment can be attributed to factors such as an increasing incidence of sudden cardiac arrest, the broadening of emergency medical services, greater availability of defibrillation devices, enhancements in cardiopulmonary resuscitation techniques, and the development of hospital-based cardiac care facilities.

The ventricular fibrillation market is projected to experience substantial expansion over the upcoming years. Its value is anticipated to reach $8.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.5%. This projected growth is driven by several factors, including the expanded deployment of public access defibrillators, increased investments in cardiac monitoring innovations, the spread of minimally invasive cardiac procedures, the escalating integration of AI-powered arrhythmia detection, and a heightened emphasis on enhancing survival outcomes. Key developments expected during this forecast timeframe encompass the wider adoption of advanced defibrillation methods, a surge in the utilization of automated external defibrillators, greater incorporation of real-time cardiac monitoring, the enlargement of emergency cardiac care facilities, and a more pronounced focus on efficient rapid response mechanisms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16818&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Ventricular Fibrillation Market?

The increasing incidence of cardiovascular diseases (CVD) is anticipated to fuel the expansion of the ventricular fibrillation market in the future. These diseases encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, high blood pressure, heart failure, and severe arrhythmias like ventricular fibrillation. Contributing factors to the rise in CVD instances include inactive lifestyles, inadequate nutrition, excess weight, tobacco use, psychological strain, and demographic shifts towards older populations. Ventricular fibrillation stands as a critical complication of CVD, frequently resulting in sudden cardiac arrest and substantially elevating the danger of death. As an illustration, the American Heart Association, a US non-profit, reported in January 2024 that the age-adjusted mortality rate for cardiovascular disease climbed to 233.3 per 100,000 in 2024, representing a 4.0% rise from 224.4 per 100,000 in 2023. Consequently, the escalating impact of cardiovascular diseases is boosting the growth of the ventricular fibrillation market.

What Major Segment Divisions Exist Within The Ventricular Fibrillation Market?

The ventricular fibrillation market covered in this report is segmented –

1) By Treatment: Cardiopulmonary Resuscitation (CPR), Defibrillation, Medication, Catheter Ablation, Left Cardiac Sympathetic Denervation

2) By Diagnostic Techniques: Electrocardiogram, Electrophysiology Study

3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-users

Subsegments:

1) By Cardiopulmonary Resuscitation (CPR): Manual Chest Compressions, Mechanical Chest Compressions

2) By Defibrillation: Automated External Defibrillators (AEDs), Implantable Cardioverter Defibrillators (ICDs), External Defibrillators

3) By Medication: Antiarrhythmic Drugs, Beta-Blockers, Vasopressors

4) By Catheter Ablation: Radiofrequency Ablation, Cryoablation, Laser Ablation

5) By Left Cardiac Sympathetic Denervation: Surgical Procedure for Sympathetic Denervation, Endoscopic Denervation Techniques

How Are Trends Shaping The Direction Of The Ventricular Fibrillation Market?

Leading companies operating within the ventricular fibrillation market are focusing their efforts on creating groundbreaking technologies, such as sophisticated artificial intelligence (AI) algorithms, to boost the precision and effectiveness of cardiac diagnostic procedures. These AI algorithms function as instructions that enable machines to analyze data, execute tasks, and make informed decisions. This significantly enhances the accuracy of atrial fibrillation (AF) detection, a major precursor to stroke, by improving the specificity and sensitivity of consumer ECG devices. For example, in January 2024, PulseAI, an Ireland-based medical technology company, developed a cutting-edge AI algorithm aimed at improving the accuracy and efficiency of ECG diagnostics. This novel technology leverages machine learning to examine electrocardiogram readings, capable of identifying even subtle patterns and anomalies that might indicate cardiovascular disease or other health conditions. By optimizing the analysis process and reducing errors in interpretation, PulseAI’s algorithm intends to enhance patient outcomes and revolutionize the domain of cardiac care.

Which Companies Are Leading Innovation In The Ventricular Fibrillation Market?

Major companies operating in the ventricular fibrillation market are Abbott Laboratories, Medtronic plc, GE HealthCare Technologies Inc., Boston Scientific Corporation, Philips Healthcare, St. Jude Medical Inc., Mindray Medical International Limited, ZOLL Medical Corporation, Biotronik, Nihon Kohden Corporation, LivaNova, Fukuda Denshi Co. Ltd., Laerdal Medical Corporation, Schiller AG, Physio-Control, Cardiac Science Corporation, CU Medical Systems Inc., Defibtech LLC, Progetti Srl, HeartSine Technologies

Read the full ventricular fibrillation market report here:

https://www.thebusinessresearchcompany.com/report/ventricular-fibrillation-global-market-report

What Are The Leading Geographic Regions In The Ventricular Fibrillation Market?

North America was the largest region in the ventricular fibrillation market in 2025. The regions covered in the ventricular fibrillation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Ventricular Fibrillation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16818&type=smp

Browse Through More Reports Similar to the Global Ventricular Fibrillation Market 2026, By The Business Research Company

Atrial Fibrillation Market Report 2026

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Cardiac Valve Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

Cardiac Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795